skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Moving towards implementation of a clinical ethics consultation program in Egyptian liver transplant units

Expert Opinion

(1552) Views  (728) Full article downloads

Authors: A H El-Elemi, G H El-Gazzaz

Published Date March 2010 Volume 2010:2 Pages 23 - 27
DOI: http://dx.doi.org/10.2147/TRRM.S8439

A H El-Elemi1, G H El-Gazzaz2

1Forensic Medicine and Clinical Toxicology Department, 2Hepatobiliary and General Surgery Department, Suez Canal University, Ismailia, Egypt

Abstract: The high prevalence of chronic liver disease in Egypt has led to increasing numbers of patients with end-stage liver disease in need of liver transplantation. To date, cadaveric liver transplantation is not legal in Egypt. However, introducing living-donor liver transplantation seems appropriate for patients who need transplantation. There are no clinical bioethicists in the Egyptian healthcare system. The idea of implementing an ethics consultation program has evolved as a response to complicated legal, ethical, and social dilemmas that accompany the transplantation process, especially in Egypt where organs are obtained by advertising without consideration of an acceptable level of risk to donors or recipients. Recommendations need to be made to start to implement peoples who do bioethics consultation in liver transplantation units. To achieve this goal there is a need to develop training standards, credentials, and certification before embarking on clinical consultation to ensure good ethics practice in Egypt.

Keywords: live donor, liver transplantation, bioethics, donor, recipient








Readers of this article also read:

Medication adherence issues in patients treated for COPD
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Ethical issues in kidney transplantation – reflections from Nigeria
Clinical intervention in aging: ethicolegal issues in assessing risk and benefit
When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum